about
Novel non-invasive methods of insulin delivery.An evaluation of the latest in vitro tools for drug metabolism studies.Targeted Drug Delivery Systems for Lung Macrophages.The formulation of nanomedicines for treating tuberculosis.Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying.Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages.Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery.Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles
P50
Q38055517-7311524A-C0EE-41AA-A457-23307BF4BDB3Q38160881-003113DD-DDD8-48D5-BB27-5A9A5E02E41AQ38268028-7B5EF394-9FB5-4DBA-B93C-E5824703468BQ38816020-81751B33-937F-4032-8753-873334882F87Q41842395-545BDA14-A08F-4CC1-986B-174CD62BF873Q48037729-483D66BE-B16A-4B60-9F70-08965C77F417Q49923188-6EC1B430-E352-401D-BED4-5D6273F0F24CQ51596702-191F8005-0ECD-4710-B865-3E1C70D2F04CQ57095087-1A081F20-53AF-4BCB-ACC4-AF18C125FACA
P50
description
researcher ORCID ID = 0000-0003-3272-8365
@en
name
Ana Costa
@ast
Ana Costa
@en
Ana Costa
@es
Ana Costa
@nl
type
label
Ana Costa
@ast
Ana Costa
@en
Ana Costa
@es
Ana Costa
@nl
prefLabel
Ana Costa
@ast
Ana Costa
@en
Ana Costa
@es
Ana Costa
@nl
P106
P1153
55496747500
55778145388
P21
P31
P496
0000-0003-3272-8365